1. Prognostic advantage of optimal medical therapy is not cancelled in hospitalized heart failure patients receiving regular hemodialysis. (14th October 2021) Authors: Takada, T; Jujo, K; Kishihara, M; Shirotani, S; Watanabe, S; Abe, T; Yoshida, A; Minami, Y; Hagiwara, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Heart failure re-hospitalization differently affects the following mortality in patients with reduced, mid-range and preserved LVEF. (14th October 2021) Authors: Abe, T; Jujo, K; Watanabe, S; Kishihara, M; Shirotani, S; Takada, T; Yoshida, A; Saito, K; Hagiwara, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Low serum chloride level gives renin-angiotensin system inhibitor a prognostic impact in heart failure patients with preserved ejection fraction. (14th October 2021) Authors: Shirotani, S; Jujo, K; Kishihara, M; Watanabe, S; Endo, N; Takada, T; Abe, T; Minami, Y; Hagiwara, N Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Beta-blocker could show the prognostic impact in heart failure patients even on the regular hemodialysis. (14th October 2021) Authors: Kishihara, M; Kentaro, J; Takuma, T; Takuro, A; Shota, S; Ayano, Y; Shonosuke, W; Yuichiro, M; Nobuhisa, H Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗